Yu Lu

2.6k total citations
122 papers, 2.1k citations indexed

About

Yu Lu is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Yu Lu has authored 122 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 71 papers in Infectious Diseases and 46 papers in Epidemiology. Recurrent topics in Yu Lu's work include Tuberculosis Research and Epidemiology (68 papers), Cancer therapeutics and mechanisms (55 papers) and Mycobacterium research and diagnosis (31 papers). Yu Lu is often cited by papers focused on Tuberculosis Research and Epidemiology (68 papers), Cancer therapeutics and mechanisms (55 papers) and Mycobacterium research and diagnosis (31 papers). Yu Lu collaborates with scholars based in China, United States and United Kingdom. Yu Lu's co-authors include Mingliang Liu, Lei Fu, Haihong Huang, Bin Wang, Jian Xu, Kai Lv, Huiyuan Guo, Apeng Wang, Bin Wang and Bin Wang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yu Lu

116 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Lu China 27 1.1k 1.0k 765 530 183 122 2.1k
Laurent R. Chiarelli Italy 30 1.5k 1.4× 582 0.6× 444 0.6× 408 0.8× 145 0.8× 93 2.7k
Anna M. Upton United States 26 1.2k 1.1× 1.2k 1.2× 335 0.4× 693 1.3× 209 1.1× 41 2.0k
João Neres United Kingdom 21 946 0.8× 647 0.6× 510 0.7× 394 0.7× 132 0.7× 29 1.5k
Maria Rosalia Pasca Italy 32 1.4k 1.3× 1.5k 1.5× 745 1.0× 1.0k 1.9× 465 2.5× 73 3.0k
Marco Pieroni Italy 23 771 0.7× 493 0.5× 683 0.9× 332 0.6× 117 0.6× 58 1.6k
Pilho Kim South Korea 18 653 0.6× 547 0.5× 488 0.6× 514 1.0× 72 0.4× 43 1.6k
Éric Arnoult United States 11 590 0.5× 572 0.6× 376 0.5× 415 0.8× 76 0.4× 17 1.4k
E. Jeffrey North United States 19 735 0.7× 942 0.9× 328 0.4× 690 1.3× 162 0.9× 29 1.5k
Jef Van Gestel Belgium 6 860 0.8× 1.3k 1.2× 300 0.4× 850 1.6× 211 1.2× 8 1.9k
Anna E. Grzegorzewicz United States 16 669 0.6× 751 0.7× 344 0.4× 529 1.0× 117 0.6× 32 1.3k

Countries citing papers authored by Yu Lu

Since Specialization
Citations

This map shows the geographic impact of Yu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lu more than expected).

Fields of papers citing papers by Yu Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lu. The network helps show where Yu Lu may publish in the future.

Co-authorship network of co-authors of Yu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Lu. A scholar is included among the top collaborators of Yu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Lu. Yu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jizhou, Na Du, Chao Ma, et al.. (2024). Design, synthesis and antimycobacterial activity of novel benzothiazinones with improved water solubility. European Journal of Medicinal Chemistry. 279. 116829–116829.
2.
Xiao, Meiling, et al.. (2024). Association Between Handgrip Strength and Mortality of Patients With Coronary Artery Disease: A Meta‐Analysis. Clinical Cardiology. 47(7). e24322–e24322. 4 indexed citations
3.
Lu, Yu, Yujia Liu, Yingxuan Wang, et al.. (2024). Increased thyroid hormone sensitivity is correlated with visceral obesity in patients with type 2 diabetes. Lipids in Health and Disease. 23(1). 337–337.
4.
Lu, Yun, et al.. (2024). Deletion of the Mycobacterium tuberculosis cyp138 gene leads to changes in membrane-related lipid composition and antibiotic susceptibility. Frontiers in Microbiology. 15. 1301204–1301204. 4 indexed citations
5.
Qin, Di, Sheng Li, Bin Wang, et al.. (2024). Tricyclic Benzo[1,3]oxazinyloxazolidinones as Potent Antibacterial Agents against Drug-Resistant Pathogens. Journal of Medicinal Chemistry. 67(18). 16088–16106. 2 indexed citations
6.
Wang, Apeng, Na Du, Huijuan Song, et al.. (2023). Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety. European Journal of Medicinal Chemistry. 258. 115545–115545. 6 indexed citations
7.
Wang, Bin, Giovanni Stelitano, Olga Riabova, et al.. (2023). Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity. Biomedicines. 11(7). 1975–1975. 2 indexed citations
8.
Wang, Wenxin, Giovanni Stelitano, Olga Riabova, et al.. (2023). Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation. European Journal of Medicinal Chemistry. 264. 115976–115976. 4 indexed citations
9.
Fu, Lei, Hui Zhu, Shuang Fu, et al.. (2023). Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline. Frontiers in Pharmacology. 14. 1154780–1154780. 1 indexed citations
10.
Shi, Rui, Bin Wang, Giovanni Stelitano, et al.. (2022). Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents. ACS Medicinal Chemistry Letters. 13(4). 593–598. 11 indexed citations
11.
Li, Peng, Lei Fu, Bin Wang, et al.. (2022). Solubility-driven optimization of benzothiopyranone salts leading to a preclinical candidate with improved pharmacokinetic properties and activity against Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 246. 114993–114993. 6 indexed citations
12.
13.
Li, Hao, Bingting Ma, Daniele Bendayan, et al.. (2021). Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis. Nature Communications. 12(1). 602–602. 55 indexed citations
14.
Wang, Bin, Giovanni Stelitano, Rui Shi, et al.. (2021). Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents. Journal of Medicinal Chemistry. 64(19). 14526–14539. 24 indexed citations
15.
Li, Peng, Bin Wang, Lei Fu, et al.. (2021). Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 222. 113603–113603. 10 indexed citations
16.
Wang, Apeng, Yun Chai, Guimin Xia, et al.. (2021). Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents. Bioorganic & Medicinal Chemistry. 53. 116529–116529. 10 indexed citations
17.
Ding, Jun, Qian Zhang, Xiaomei Wang, et al.. (2020). Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria. Molecules. 25(10). 2431–2431. 9 indexed citations
18.
Lu, Yu, Jie Zeng, Shi Yang, et al.. (2020). Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV‐related hepatocellular carcinoma in a Guangxi population. Journal of Clinical Laboratory Analysis. 34(8). e23310–e23310. 3 indexed citations
19.
Li, Linhu, Yuanyuan Jin, Bin Wang, et al.. (2017). A structure‐based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study. Chemical Biology & Drug Design. 91(3). 769–780. 2 indexed citations
20.
Zhang, Tingting, Weiyi Shen, Mingliang Liu, et al.. (2015). Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety. European Journal of Medicinal Chemistry. 104. 73–85. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent R. Chiarelli Breakdown of academic impact, for papers by Anna M. Upton Breakdown of academic impact, for papers by João Neres Breakdown of academic impact, for papers by Maria Rosalia Pasca Breakdown of academic impact, for papers by Marco Pieroni Breakdown of academic impact, for papers by Pilho Kim Breakdown of academic impact, for papers by Éric Arnoult Breakdown of academic impact, for papers by E. Jeffrey North Breakdown of academic impact, for papers by Jef Van Gestel Breakdown of academic impact, for papers by Anna E. Grzegorzewicz
Rankless by CCL
2026